The Sudden, Inevitable Rewiring of the American Left
By Andrew Burmon,
Inverse
| 11. 18. 2016
When the Democratic Party gave up on technology, progressivism malfunctioned. Now, technophile liberals are preparing to fix a movement.
In 1962, the year President John F. Kennedy promised a crowd of Rice University students the moon, 2.6 percent of the federal budget was allocated for non-defense research and development. By 1967, that number sat at 5.8 percent, and JFK lay under an eternal flame. Neil Armstrong took his lunar stroll in 1969, and returned to slash budgets as non-defense research had crashed to 4.3 percent on its way toward today’s 1.6 percent. The American government currently spends $67.8 billion annually on the quest for knowledge, at least $40 billion less than China, against the $78.9 billion it spends lubing the Defense Departments sprawling skunkworks.
The privatization of innovation runs counter to broadly accepted narratives of progress, the leftist, Enlightenment-era idea that “natural orders” are perpetually ripe for disruption. The technological half of this premise drove American policy through the 1960s, with Eisenhower embracing the pill, and rejecting the pre-JFK military industrial complex. But when workplace computing and consumer...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...